Clinical response to apatinib monotherapy in advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Clinical response to apatinib monotherapy in advanced non-small cell lung cancer

Published:2017-12-15 Issue:3 Volume:14 Page:264-269
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Xu Jianping¹,Liu Xiaoyan¹,Yang Sheng¹,Zhang Xiangru¹,Shi Yuankai¹^ORCID

Affiliation:

1. Department of Medical Oncology; Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs; National Cancer Center/Cancer Hospital; Chinese Academy of Medical Sciences & Peking Union Medical College; Beijing 100021 China

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12834/fullpdf

Reference39 articles.

1. Cancer statistics in China;Chen;CA Cancer J Clin,2015

2. VEGF receptor signaling in tumor angiogenesis;McMahon;Oncologist,2000

3. China experts consensus on the diagnosis and treatment of advanced stage primary lung cancer (2016 version);Shi;Asia Pac J Clin Oncol,2017

4. Prognostic significance of interleukin-17 in solid tumors: a meta-analysis.;Zeng;Int J Clin Exp Med,2015

5. Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction;Li;J Clin Oncol,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of apatinib plus chemotherapy vs. chemotherapy alone for the treatment of advanced‑stage non‑small cell lung cancer: A meta‑analysis;Oncology Letters;2023-11-17

2. Efficacy of apatinib+radiotherapy vs radiotherapy alone in patients with advanced multiline therapy failure for non small cell lung cancer with brain metastasis;The British Journal of Radiology;2023-09

3. Advances in Anti-Angiogenesis Therapy for Middle and Advanced Cervical Cancer;Advances in Clinical Medicine;2023

4. “Highly Exposed Chinese Herbal Medicine” Combined With Apatinib as Maintenance Treatment Following First-Line or Second-Line Chemotherapy for Extensive-Stage Small-Cell Lung Cancer: A Single-Arm, Prospective Study;Dose-Response;2021-10

5. Clinical efficacy of apatinib as a second-line treatment for advanced pancreatic cancer in a Chinese tertiary cancer health facility;Tropical Journal of Pharmaceutical Research;2021-07-01